Early asset prioritization in oncology CASE STUDY www.course5i.com Continuous monitoring of MOA landscape for early-stage oncology assets provided an assessment of impact to our client’s strategic goals in the therapy area Asset prioritization model strengthened client’s oncology franchise by evaluating new opportunities, facilitating R&D efforts and improving the positioning of their pipeline products Business Impact Client Leading Pharma Company Therapy Area Oncology Project objectives To monitor early assets in oncology by MOA and their classes To provide insights on key competitor development, and provide inputs into eective operational and strategic decision-making Scope MOAs of interest categorized by priority: High: IDO, LAG-3, CSF-1R, GITR, OX40, 4-1BB Medium: Anti-KI

Join for free to read